Tirzepatide benefits people with obesity, kidney disease and heart failure
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...
Medindia3d
Tirzepatide: Combating Obesity, Kidney Disease, and Heart Failure Together
Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...
ACC 25: tirzepatide influences clinical trajectory of patients with HFpEF and obesity
GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.
News-Medical.Net on MSN4d
Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...
EurekAlert!5d
Tirzepatide benefits people with obesity, kidney disease and heart failure
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year ...
Physician's Weekly4d
Epicardial Fat and Heart Failure with Preserved Ejection Fraction
The following is a summary of "Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure ...